Please use this identifier to cite or link to this item:
Title: Biomarkers of Morbid Obesity and Prediabetes by Metabolomic Profiling of Human Discordant Phenotypes.
Authors: Tulipani, Sara
Palau-Rodriguez, Magali
Miñarro Alonso, Antonio
Cardona, Fernando
Marco-Ramell, Anna
Zonja, Bozo
Lopez de Alda, Miren
Muñoz-Garach, Araceli
Sanchez-Pla, Alejandro
Tinahones, Francisco J
Andres-Lacueva, Cristina
Keywords: mass spectrometry;metabolic markers;obesity;observational study;prediabetes
metadata.dc.subject.mesh: Adult
Diabetes Mellitus, Type 2
Middle Aged
Obesity, Morbid
Prediabetic State
Issue Date: 5-Oct-2016
Abstract: Metabolomic studies aimed to dissect the connection between the development of type 2 diabetes and obesity are still scarce. In the present study, fasting serum from sixty-four adult individuals classified into four sex-matched groups by their BMI [non-obese versus morbid obese] and the increased risk of developing diabetes [prediabetic insulin resistant state versus non-prediabetic non-insulin resistant] was analyzed by LC- and FIA-ESI-MS/MS-driven metabolomic approaches. Altered levels of [lyso]glycerophospholipids was the most specific metabolic trait associated to morbid obesity, particularly lysophosphatidylcholines acylated with margaric, oleic and linoleic acids [lysoPC C17:0: R=-0.56, p=0.0003; lysoPC C18:1: R=-0.61, p=0.0001; lysoPC C18:2 R=-0.64, p
metadata.dc.identifier.doi: 10.1016/j.cca.2016.10.005
Appears in Collections:Producción 2020

Files in This Item:
There are no files associated with this item.

This item is protected by original copyright

This item is licensed under a Creative Commons License Creative Commons